ACC 2017, 3/30/2017 – Poor Outcomes for Bioresorbable Stents in Small Coronary Arteries
Reporter: Aviva Lev-Ari, PhD, RN
WATCH VIDEO:
Bioresorbable Stent Comparable to Xience at Two Years, With Concerns
Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses the two year outcomes of the ABSORB III trial of Absorb vs. Xience. The late-breaking trial was presented at ACC 2017. Read the article on the ABSORB III results. Watch a VIDEO with Gregg Stone, M.D., “Poor Outcomes for Bioresorbable Stents in Small Coronary Arteries.”
SOURCE
https://www.dicardiology.com/videos/video-bioresorbable-stent-comparable-xience-two-years-concerns
Leave a Reply